ProScientois a clinical research organization (CRO) exclusively focused on NASH,diabetes, obesity and related metabolic diseases. ProSciento works withbiopharma companies worldwide to support their outsourced clinical researchneeds with full-scope services for multinational, early development clinicaltrial programs. Founded in 2003, ProSciento has conducted 280+ clinicalprojects for diabetes, NASH and obesity and contributed to the development of15+ approved metabolic drugs and devices.

‍